This is a routine annual meeting with no immediate financial impact. Monitor for any changes in governance or compensation policies.
TRVI drugs
TRVI drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 22 $14.80entry
- T+1 · 7mo ago −4.12%α −3.73% · $14.19
- T+5 · 7mo ago −7.97%α −8.03% · $13.62
- T+20 · 6mo ago −10.54%α −13.71% · $13.24
- T+60 · 4mo ago +28.85%α +24.07% · $19.07
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Trevi Therapeutics is holding its 2026 annual meeting where shareholders will vote on several proposals including electing a director, ratifying auditors, approving executive compensation, amending the stock incentive plan, and increasing authorized shares. This is a routine annual shareholder meeting.
Key Financial Metrics
Key Facts
- Annual meeting to vote on director election, auditor ratification, executive compensation, stock incentive plan amendment, and share authorization
- Board recommends voting for all proposals
- Meeting date: June 3, 2026
Financial Impact
No immediate financial impact
Risk Factors
- Potential shareholder dissent on executive compensation
- Possible opposition to share increase
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-166693 |
| Document: 0001193125-26-166693-index-headers.html | 0001193125-26-166693 |
| Document: 0001193125-26-166693-index.html | 0001193125-26-166693 |
| Document: 0001193125-26-166693.txt | 0001193125-26-166693 |
Track record
12 reports on TRVI
3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +15.38% at T+60 after the Mar 9, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K Neutral 4/10 Entry $14.91 Now $13.29 −10.87% settles Dec 9
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $13.52 Now $13.29 −1.70% settles Nov 25
- Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $13.46 to $18.40 Now $13.29 −1.26% ▲ +36.70% +34.81% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $13.46 to $18.40 Now $13.29 −1.26% ▲ +36.70% +34.81% vs SPY
- Apr 21, 202629w ago DEFA14A Neutral 3/10 Viewing Entry $14.80 to $13.24 Now $13.29 −10.20% ▼ −10.54% −13.71% vs SPY
- Apr 20, 202630w ago Press Release Neutral 5/10 Entry $14.62 to $13.43 Now $13.29 −9.10% ▼ −8.14% −13.05% vs SPY
- Apr 17, 202630w ago 424B5 Bearish 7/10 Entry $15.40 to $13.43 Now $13.29 +13.70% ▲ +12.79% +16.99% vs SPY
- Apr 17, 202630w ago 8-K Bearish 7/10 Entry $15.23 to $15.08 Now $13.29 +12.74% ▲ +0.98% +6.36% vs SPY
- Apr 16, 202630w ago Press Release Neutral 6/10 Entry $15.23 to $15.08 Now $13.29 −12.74% ▼ −0.98% −6.36% vs SPY
- Mar 17, 202634w ago Press Release Mixed 6/10 Entry $10.69 to $14.54 Now $13.29 +24.32% ▲ +36.02% +29.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers